Victor Kostenko

4.1k citations
7 papers · 3.1k · 2 hit papers · h-index 7

Impact in

Papers in

Victor Kostenko

7 papers receiving 3k citations

Victor Kostenko's Hit Papers

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial 2019 · 2.3k citations
2.3k0+2+4Years since publication5001k1.5k2k

Peers

Victor Kostenko
Comparison fields: 5 of 77
  • Endocrinology, Diabetes and Metabolism 2.1k
  • Nephrology 416
  • Cardiology and Cardiovascular Medicine 463
  • Transplantation 20
  • Pharmacology 81
Replace Ondrej Jerabek with:
Ondrej Jerabek United Kingdom
Ingo Weigmann Germany
Doina Sipciu United States
Jan Malecha
Sergey N. Tereschenko Russia
Ji‐Hyun Kim South Korea
Patricia Ely Pizzato United States
Anna Bochenek Türkiye
Ludmila Krylova Austria
Sergey R. Gilyarevsky Russia
Victor Kostenko relative to Ondrej Jerabek United Kingdom Ondrej Jerabek's profile →
Citations per field
00.5×2×3×4×
Ondrej Jerabek · 1×
Citations per year

Countries citing papers authored by Victor Kostenko

Since Specialization
Citations

This map shows the geographic impact of Victor Kostenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Kostenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Kostenko more than expected).

Fields of papers citing papers by Victor Kostenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor Kostenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Kostenko. The network helps show where Victor Kostenko may publish in the future.

No co-authors to show.

All Works

7 of 7 papers shown
#Work
1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hit paper breakdown →
20192345
2
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hit paper breakdown →
2019498
3 2019160
4 201748
5 202030
6 202212
7
Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome The VISTA-16 Randomized Clinical Trial
20148

About Victor Kostenko

Victor Kostenko is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Nephrology, Surgery and Nuclear Energy and Engineering, having authored 7 papers that have together received 3.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Chronic Kidney Disease and Diabetes (1 paper), Lipoproteins and Cardiovascular Health (1 paper), Heart Failure Treatment and Management (1 paper), Atrial Fibrillation Management and Outcomes (1 paper) and Acute Myocardial Infarction Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.1k citations), Nephrology (416 citations), Cardiology and Cardiovascular Medicine (463 citations), Transplantation (20 citations) and Pharmacology (81 citations). Their work appears in journals such as The Lancet, Clinical Research in Cardiology, Diabetes Care, Journal of the American College of Cardiology and Figshare.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact